coumarin and cyclopropanecarboxamide

coumarin has been researched along with cyclopropanecarboxamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Javaid, A; Jokinen, EM; Juvonen, RO; Lehtonen, M; Pentikäinen, OT; Raunio, H	1

Other Studies

1 other study(ies) available for coumarin and cyclopropanecarboxamide

Article	Year
Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study. Chemical biology & drug design, 2020, Volume: 95, Issue:5 Topics: Amides; Benzoflavones; Binding Sites; Catalytic Domain; Coumarins; Cyclopropanes; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P450 Family 1; Humans; Liver; Molecular Dynamics Simulation; Oxidation-Reduction	2020

Article

Year

Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.

Chemical biology & drug design, 2020, Volume: 95, Issue:5

Topics: Amides; Benzoflavones; Binding Sites; Catalytic Domain; Coumarins; Cyclopropanes; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P450 Family 1; Humans; Liver; Molecular Dynamics Simulation; Oxidation-Reduction

2020